Galecto News - Web may 10, 2024 7:46 am et senti biosciences, inc. Web globenewswire • 16 hours ago. Announces next steps for clinical development plan in severe liver diseases. (glto) upgraded to strong buy: Meghavi singh, sa news editor. What does it mean for the stock? Web news release details < back.
Portfolio Hadean Ventures
Web may 10, 2024 7:46 am et senti biosciences, inc. Meghavi singh, sa news editor. Announces next steps for clinical development plan in severe liver diseases. Web news release details < back. (glto) upgraded to strong buy:
Galecto reports midstage lung disease trial fail, drops lead candidate
(glto) upgraded to strong buy: Web news release details < back. What does it mean for the stock? Web globenewswire • 16 hours ago. Meghavi singh, sa news editor.
Galecto Announces Clinical Collaboration with Roche for Phase 2 Trial
Web may 10, 2024 7:46 am et senti biosciences, inc. Web globenewswire • 16 hours ago. Announces next steps for clinical development plan in severe liver diseases. (glto) upgraded to strong buy: What does it mean for the stock?
Galecto Finalizes Plan For 85 Million IPO (NASDAQGLTO) Seeking Alpha
(glto) upgraded to strong buy: What does it mean for the stock? Announces next steps for clinical development plan in severe liver diseases. Web globenewswire • 16 hours ago. Web news release details < back.
Galecto raise US85m in Nasdaq IPO European Biotechnology
Announces next steps for clinical development plan in severe liver diseases. What does it mean for the stock? (glto) upgraded to strong buy: Meghavi singh, sa news editor. Web globenewswire • 16 hours ago.
Galecto Finalizes Plan For 85 Million IPO (NASDAQGLTO) Seeking Alpha
What does it mean for the stock? Web globenewswire • 16 hours ago. Announces next steps for clinical development plan in severe liver diseases. Meghavi singh, sa news editor. Web news release details < back.
Galecto (GLTO) Phase 2a Trial Reduces Fibrosis of Bone Marrow in
Web news release details < back. Announces next steps for clinical development plan in severe liver diseases. Web globenewswire • 16 hours ago. What does it mean for the stock? (glto) upgraded to strong buy:
Galecto Announces First Patient Enrolled in Phase 2 Trial of GB1211 in
Meghavi singh, sa news editor. Announces next steps for clinical development plan in severe liver diseases. Web may 10, 2024 7:46 am et senti biosciences, inc. Web globenewswire • 16 hours ago. What does it mean for the stock?
Galecto (GLTO) Investor Presentation Slideshow (NASDAQGLTO
Web news release details < back. Web may 10, 2024 7:46 am et senti biosciences, inc. What does it mean for the stock? Web globenewswire • 16 hours ago. Announces next steps for clinical development plan in severe liver diseases.
Galecto Announces Poster Presentation Detailing Results from
Meghavi singh, sa news editor. Web globenewswire • 16 hours ago. Web news release details < back. Web may 10, 2024 7:46 am et senti biosciences, inc. Announces next steps for clinical development plan in severe liver diseases.
(glto) upgraded to strong buy: Web globenewswire • 16 hours ago. What does it mean for the stock? Announces next steps for clinical development plan in severe liver diseases. Meghavi singh, sa news editor. Web news release details < back. Web may 10, 2024 7:46 am et senti biosciences, inc.